WAI CHUN BIOTEC: POSSIBLE DELAY IN PUBLICATION OF ANNUAL RESULTS AND POSTPONEMENT OF BOARD MEETING
CICC Securities: The chemical industry continued to fluctuate in the first half of the year, with strong tire exports and double growth in revenue and performance.
In the first half of 2024, the chemical industry achieved revenue of 1237.63 billion yuan, a year-on-year increase of +4.2%; net income attributable to the company was 75.25 billion yuan, a year-on-year increase of +0.8%.
Sealand Securities: The cyclical upturn of PX and pure benzene is expected.
The pure benzene industry has limited new production capacity, and the supply-demand imbalance is expected to continue. Stimulated by demand, it is expected that the global pure benzene industry operating rate will rebound strongly from 2024 to 2026.
Wai Chun Biotech (00660.HK) appointed Chang Qing (Hong Kong) as the auditor.
On July 26th, Glory Hui reported that, in order to seek better audit services and improve corporate governance, following the recommendation of the Company Audit Committee, the board of directors has appointed Changqing (Hong Kong) Certified Public Accountants Co., Ltd. to replace Zhongzheng Tianheng Certified Public Accountants as the company's auditors, effective from July 26, 2024, and serve until the end of the next shareholder's annual meeting.
China International Capital Corporation: The internationalization level of domestic chemical industry leading enterprises is relatively low, and the route of capacity going abroad is a must.
Exporting production capacity is an important way for Chinese chemical enterprises to promote international development, expand markets, and achieve win-win cooperation, and it is also a necessary path for excellent Chinese chemical enterprises to further grow and strengthen.
Weijun Biotech appoints Van der Weil as company secretary
Weijun Biotechnology (00660) issued an announcement to appoint Mr. Fan Dewei as company secretary under section 3.28 of the listing rules, effective from June 1, 2024.
Weijun Biotechnology (00660) appoints Van der Wai as company secretary
Weijun Biotechnology (00660) issued an announcement to appoint Mr. Fan Dewei as a person under section 3.28 of the listing rules...
Wei Jun Biotechnology (00660.HK): Lin Qiji resigns as company secretary
Gelonghui, May 21丨Weijun Biotechnology (00660.HK) announced the resignation of Mr. Lin Qiji as company secretary and authorized representative, effective May 21, 2024.
Wai Chun Biotechnology (00660) appoints Lam Kai-ki as company secretary and authorized representative
Zhitong Finance App News, Wei Jun Biotechnology (00660) announced that Li Huifang has resigned as the company's company secretary and no longer serves as the company's authorized representative. Lin Qiji has been appointed as the company's secretary and authorized representative, effective March 28, 2024.
WAI CHUN BIOTEC: Interim Report 2023/24
Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows
Weijun Biotechnology (00660) announced interim results. Shareholders' share loss of HK$6.734 million narrowed 14.01% year-on-year
According to the Zhitong Finance App, Weijun Biotechnology (00660) announced results for the six months ended December 31, 2023. The group achieved revenue of HK$190 million during the period, a year-on-year decrease of 53.01%; the loss due to company owners during the period was HK$6.734 million, a year-on-year decrease of 14.01%; the basic loss per share was HK$3.93. According to the announcement, the decline in revenue was due to a decrease in market consumption and demand during the period.
WAI CHUN BIOTEC: INTERIM RESULTS FOR THE SIX MONTHSENDED 31 DECEMBER 2023
Weijun Biotechnology (00660.HK) will hold a board meeting on February 29 to approve the interim results
Gelonghui, Feb. 19 | Weijun Biotechnology (00660.HK) announced that the company will hold a board meeting on February 29, 2024 to consider and approve the unaudited interim results announcement and release of the company and its subsidiaries for the six months ended December 31, 2023.
Wai Chun Biotechnology (00660.HK): Lee Wai Fong Appointed as Secretary and Authorised Representative
Gelonghui, Feb. 15 | Weijun Biotechnology (00660.HK) announced that He Xiaoping has proposed to resign as company secretary and terminated his position as authorized representative of the company under section 3.05 of the Hong Kong Stock Exchange Limited securities listing rules. Li Huifang has been appointed as company secretary and authorized representative with effect from February 15, 2024.
Weijun Biotechnology (00660) appoints Lee Wai Fong as company secretary and authorized representative
Weijun Biotechnology (00660) announced that He Xiaoping has resigned as the company's company secretary and terminated the company's authorization...
Winding-Up Petition Against Wai Chun Bio-Technology Withdrawn
Weijun Biotechnology (00660): The winding-up petition was withdrawn
Weijun Biotechnology (00660) issued an announcement. The company and the petitioner have submitted a petition on November 28, 2023...
Guoxin Securities's 24-year chemical strategy: the economy is expected to bottom out and rebound, optimistic about the direction of upstream core resource products and downstream emerging chemicals
We are more optimistic about the investment direction of upstream core resource products and emerging chemicals where downstream demand is expected to continue to grow.
Business Society: The slight adjustment in phosphoric acid prices is expected to be weak in the short-term market, mainly
As of November 22, the average domestic reference price of 85 caloric phosphoric acid was 7080 yuan/ton, down nearly 2% from the average reference price of 7,200 yuan/ton on November 1.
No Data
No Data